Navigation Links
NIH expands key pharmacogenomics resource
Date:9/7/2010

To help advance research on how genes affect responses to medicines, the National Institutes of Health is spending $15 million over five years to expand a key resource, the Pharmacogenomics Knowledge Base (PharmGKB), http://www.pharmgkb.org/ .

The goal of pharmacogenomics is to use information about a patient's genetic make-up to optimize his or her medical treatment. As the field has grown, so has PharmGKB. Begun in 2000 to catalog links between human genetic variation and drug responses, the PharmGKB Web site is now a centralized hub that collects, analyzes and integrates data for national and international research consortia. All information in PharmGKB is carefully curated, meaning it is annotated and cross-referenced with related research data.

"PharmGKB is a trusted source for curated knowledge about pharmacogenomics," said Jeremy M. Berg, director of the National Institute of General Medical Sciences (NIGMS), which administers the PharmGKB grant. "It plays a critical role in moving us closer to the goal of personalized prescriptions, meaning each patient receives a safe and effective drug dose based on his or her individual characteristics."

PharmGKB, which is freely available to the scientific community, identifies biochemical pathways influenced by specific drugs and provides detailed summaries of key genes that influence a person's response to a broad array of medicines. PharmGKB also includes six staff scientists and six software engineers who conduct research, collaborate with other investigators and build the software infrastructure supporting PharmGKB.

In a 2009 study PharmGKB researchers, together with scientists from Europe, Asia, South America and the Middle East, were able to utilize patients' genetic information to better predict their optimal doses of warfarin, a widely used blood thinner that is tricky to dose. The concept of using genotyping in this way is now being tested in a large-scale clinical trial sponsored by the NIH's National Heart, Lung, and Blood Institute.

PharmGKB and other scientists also analyzed a person's entire genome, to identify variations associated with disease risk and adverse drug reactions.

During the next five years, PharmGKB plans to:

  • Develop tools that automatically extract information from the biomedical literature and key databases.

  • Intensify its focus on understanding the molecular basis for drug toxicity and multiple-drug interactions, information that may help improve the safety and efficacy of medicines.

  • Analyze the genomes of additional individuals, including a family that has volunteered to be studied.

  • Develop guidelines for doctors about the use of genetic tests to customize dosages when prescribing certain medicines.

"PharmGKB has become a powerful resource not only by providing high-quality information, but also by bringing researchers together to share ideas and collaborate," said Rochelle M. Long, Ph.D., who directs pharmacogenomics research programs at NIGMS. "We anticipate that such collaborations will continue to grow for the next five years."

PharmGKB is part of a broader NIH pharmacogenomics initiative that includes individual research projects and a nationwide research consortium, the NIH Pharmacogenomics Research Network (PGRN). New PGRN grants are also being announced at this time.


'/>"/>

Contact: Alisa Zapp Machalek
alisa.machalek@nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences
Source:Eurekalert

Related biology news :

1. Core knowledge of tree fruit expands with apple genome sequencing
2. High-resolution imaging expands vision research of live birds of prey
3. Orbel Expands Fabric over Foam Gasket Product Line
4. HIV vaccine strategy expands immune responses
5. Identive Group Expands Executive Management Team
6. Identive Group Expands Executive Management Team
7. Nepal expands critical tiger habitat
8. ID Analytics Expands Availability of On-Demand Identity Intelligence Solutions for the Government Market
9. Fujitsu Expands Support for Ethernet Networks With New Additions to XG Switch Product Line
10. NIH expands Human Microbiome Project; funds sequencing centers and disease projects
11. Fetal alcohol syndrome testing expands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology: